21st August 2018: A new chapter in the provision of advanced cancer care in the North-East of England has started with the official opening of the Rutherford Cancer Centre North East.
8th August 2018: The provision of advanced cancer treatment in the South of England passed a key milestone today with the arrival of the first high energy proton beam therapy system in the region.
7th August 2018: The first patient to be treated with high energy proton beam therapy for breast cancer in the UK commenced treatment this week at the Rutherford Cancer Centre South Wales.
11th April 2018: Proton Partners International announced today it has treated the first patient in the UK with high energy proton beam therapy.
20th March 2018: Proton Partners International has been granted formal technical and regulatory approval from Healthcare Inspectorate Wales to begin treating patients with proton beam therapy at its Rutherford Cancer Centre in Wales.
12th March 2018: IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed three new contracts with Proton Partners International, to install three Proteus®ONE* compact proton therapy solutions across the UK.
7th March 2018: Wales has shown ‘outstanding’ vision in helping to develop innovative proton beam therapy services for cancer patients.
22nd February 2018: Proton Partners International and Ion Beam Applications (IBA) Group, the world’s leading developers of high energy proton beam therapy centres and systems, have officially completed testing on the UK’s first high energy proton beam machine, the Proteus®ONE.
6th February 2018: The first proton beam therapy system to be installed in the North-East of England was delivered today by Proton Partners International Ltd.
Proton Partners International Ltd., the company bringing high energy proton beam therapy to the UK, has today announced a new construction partnership for its £35 million oncology centre, which will be known as the Rutherford Cancer Centre North West.
The agreement is between the subsidiary of Proton Partners International, Rutherford Estates and Interserve, the international support services and construction group. Work on site is scheduled to commence on January 8th, 2018.
The partnership is of strategic importance with the centre’s location in the growing £1 billion Knowledge Quarter (KQ) in Liverpool’s Paddington Village and will see the construction of a two-storey cancer treatment facility.
The Rutherford Cancer Centre North West will bring the most advanced treatments in cancer care to the region, including high energy proton beam therapy (a treatment not currently available in the UK), as well as the latest technology on the market to deliver radiotherapy, chemotherapy, imaging and diagnostics.
Conventional treatments will be available from 2018 and high-energy proton beam therapy will be available from 2019. The centre will treat up to 500 patients a year and treatment will be available to medically-insured private patients, self-paying patients and patients referred by the NHS.
Mike Moran, chief executive officer of Proton Partners International, said: “We are really pleased to announce that we have appointed Interserve, one of the world’s foremost support services and construction companies, as our partners. We are confident that their team will provide the very best quality and expertise in building our Rutherford Cancer Centre in Liverpool”.
Phil Shaw, divisional director at Interserve Construction, said: “The team’s knowledge, experience, innovation and expertise, together with a compelling offer at interview contributed to winning this contract. We are delighted to be embarking on a journey with Proton Partners International to jointly deliver a successful project”.